Andersen CY

No ORCID on file · 5 papers in corpus
other 2026
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2026.100454

BACKGROUND: The GnRH antagonist protocol is widely used in IVF/ICSI treatments. It involves daily injections of a GnRH antagonist starting on stimulation day 5 or later to prevent premature ovulation by suppressing the endogenous gonadotrop…

rct 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1004596

BACKGROUND: Choriogonadotropin (CG) beta (FE 999302), a novel recombinant human (h)CG produced by a human cell line, has a longer half-life and higher potency than CG alfa produced by a Chinese hamster ovary cell line. hCG augments steroid …

observational 2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-019-01633-4

PURPOSE: To evaluate the association between anti-Müllerian hormone (AMH) and follicle density in infertile women with diminished ovarian reserve (DOR) versus women with normal ovarian reserve? METHODS: Case-control study comparing follicl…

nonrandomized-trial 2009
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2009.02.001

OBJECTIVE: The key enzyme in the biosynthesis of estradiol, aromatase, has been demonstrated within endometriosis. Combined administration of aromatase inhibitor and GnRH-agonist may efficiently suppress estrogen biosynthesis through a comb…

review 1993
Ugeskrift for laeger

Medical indications for in vitro fertilization and embryo transfer (IVF-ET) internationally and in Denmark are reviewed. Reports from large international centres document that tubal infertility, unexplained infertility, endometriosis and ma…